Cargando…
Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson’s disease-specific hepatocytes
Wilson’s disease (WD) is a copper metabolic disorder caused by a defective ATP7B function. Conventional therapies cause severe side effects and significant variation in efficacy, according to cohort studies. Thus, exploring new therapeutic approaches to prevent progression to liver failure is urgent...
Autores principales: | Song, Dan, Takahashi, Gou, Zheng, Yun-Wen, Matsuo-Takasaki, Mami, Li, Jingyue, Takami, Miho, An, Yuri, Hemmi, Yasuko, Miharada, Natsumi, Fujioka, Tsuyoshi, Noguchi, Michiya, Nakajima, Takashi, Saito, Megumu K, Nakamura, Yukio, Oda, Tatsuya, Miyaoka, Yuichiro, Hayashi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616579/ https://www.ncbi.nlm.nih.gov/pubmed/35388883 http://dx.doi.org/10.1093/hmg/ddac080 |
Ejemplares similares
-
Diagnostic Value of Ceruloplasmin in the Diagnosis of Pediatric Wilson's Disease
por: Kim, Jung Ah, et al.
Publicado: (2015) -
Assessment of the diagnostic value of serum ceruloplasmin for Wilson’s disease in children
por: Lu, Xinshuo, et al.
Publicado: (2022) -
Studying Abnormal Chromosomal Diseases Using Patient-Derived Induced Pluripotent Stem Cells
por: Hayashi, Yohei, et al.
Publicado: (2020) -
Role of serum ceruloplasmin in the diagnosis of Wilson's disease: A large Chinese study
por: Yang, Yue, et al.
Publicado: (2022) -
Age and Serum Creatinine Can Differentiate Wilson Disease Patients with Pseudonormal Ceruloplasmin
por: Chen, Lin, et al.
Publicado: (2023)